Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | High | NA |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.72 | 1.74 |
NAV | ₹75.20 | ₹81.90 |
Fund Started | 16 Feb 2004 | 17 Nov 2003 |
Fund Size | ₹3188.48 Cr | ₹3406.09 Cr |
Exit Load | Exit load for units in excess of 30% of the investment,1% will be charged for redemption within 1 year | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.16% | 7.11% |
3 Year | 11.13% | 12.00% |
5 Year | 10.80% | 12.56% |
1 Year
3 Year
5 Year
Equity | 22.00% | 20.96% |
Cash | 5.10% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 1.69% |
SBI Life Insurance Company Ltd. | 1.36% |
Maruti Suzuki India Ltd. | 1.13% |
Sun Pharmaceutical Industries Ltd. | 1.07% |
HDFC Bank Ltd. | 1.04% |
Axis Bank Ltd. | 0.94% |
NTPC Ltd. | 0.86% |
HDFC Life Insurance Co Ltd. | 0.82% |
Bharti Airtel Ltd. | 0.81% |
Gland Pharma Ltd. | 0.78% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Ritesh Lunawat | Dhruv Muchhal |
Start Date | 28 Dec 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investments in money market and debt instruments. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 16 Feb 2004 | 17 Nov 2003 |
Description
Launch Date